GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Question] Poland — has anyone got a straight answer on 503B — 19 comments in the full submission. View in context.
376
c/compounding·submitted 2 years ago by u/liver_enzyme_liz

[Question] Poland — has anyone got a straight answer on 503B

Questionbranch of 8 comments

Something I noticed reading old threads that I have not seen said out loud. The advice on 503B in this community changed substantially around the start of last year, and nobody went back and updated the older posts. So depending on which thread the search engine hands you, you get two contradictory answers with the…

Read the full submission and all 19 comments →

This branch

8 comments, started 2 years ago
u/maren_sorensen-13 points·2 years ago

Did they tell you their API source or dodge the question?

replysharereportpermalink
u/amara_kuipers1 point·2 years ago

shortage list status is state board, check the actual list

replysharereportpermalink
u/honest_syringe_20251 point·2 years ago

API transparency is the question that separates good compounders from sketchy ones

replysharereportpermalink
[deleted]1 point·2 years ago

[deleted]

replysharereportpermalink
u/yannick_barros-18 points·2 years ago

the 503A/503B distinction is load-bearing, do not blur it

replysharereportpermalink
u/honest_syringe1 point·2 years ago

Yeah, 503A and 503B are different regulatory animals.

replysharereportpermalink
u/ffmi_watcher1 point·2 years ago

regulatory claims need a citation to the actual rule, not interpretation

replysharereportpermalink
u/liver_enzyme_lizOP1 point·2 years ago

the shortage list is temporary, it ends and compounding becomes illegal again

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/compounding
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/formulary_fighteru/usp_appendixu/quiet_moderatoru/prior_auth_pain
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →